Joanna Śniecikowska

Assistant Professor

Uniwersytet Jagiellonski Collegium Medicum

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Joanna Śniecikowska is an Assistant Professor at Uniwersytet Jagielloński w Krakowie Collegium Medicum in Poland. Her research primarily focuses on neuropharmacology, with recent articles addressing topics such as GABAergic hypofunction in schizophrenia, serotonin receptor ligands, and multifunctional agents for Alzheimer's disease. She has contributed significantly to studies on the pharmacological management of neuropsychiatric symptoms and the development of new therapeutic agents for mood disorders.

Articles (9)

Year:

2025

Year:

2025

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

Jagiellonian University Medical College

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joanna Śniecikowska

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Targeting GABAergic Hypofunction Associated with Schizophrenia: Identification of α1β2γ2GABA-A Receptor Ligands with Neuroprotective and Antipsychotic Properties

Discovery of NLX-266, an Orally Available and Metabolically Stable ERK1/2-Biased 5-HT1AR Agonist with Superior Antidepressant and Antiparkinsonian Activity

Serotonin 5-HT<sub>6</sub> Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer’s Disease

The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress

Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT<inf>6</inf>R antagonists with β-amyloid anti-aggregation properties

Multifunctional Arylsulfone and Arylsulfonamide-Based Ligands with Prominent Mood-Modulating Activity and Benign Safety Profile, Targeting Neuropsychiatric Symptoms of Dementia

Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile

Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates

Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD)

Collaborators (7)

Monika Marcinkowska

Marcin Kolaczkowski

Alicja Gawalska

Agnieszka Zagórska

Anna Wieckowska

Adam Bucki

Maria Walczak

Make your next move.